Novartis arthritis drug " narrowly misses " against Humira

Novartis said a trial fell short of producing statistical evidence that its anti-inflammatory drug, Cosentyx, can beat the world ' s best-selling drug Humira in treating arthritis.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news